ADHERENCE TO AISF RECOMMENDATIONS FOR INTEGRATED MANAGEMENT OF HEPATOCELLULAR CARCINOMA IN A REAL-WORLD CLINICAL PRACTICE

被引：0
|
作者：
Piai, G. [1 ]
Messina, V. [2 ]
Valente, G. [1 ]
Rinaldi, L. [1 ]
Moggio, G. [3 ]
机构：
[1] AORN St Anna & San Sebastiano, UOSD Fisiol Epat Con Serv Assistenza Trapiantandi, Caserta, Italy
[2] AORN St Anna & San Sebastiano, UOS Ottimizzaz & Monitoraggio Epatiti Croniche Vi, Caserta, Italy
[3] AORN St Anna & San Sebastiano, UOSD Radiol Interventist, Caserta, Italy
来源：
DIGESTIVE AND LIVER DISEASE | 2015年 / 47卷
关键词：
D O I：
10.1016/j.dld.2015.01.058
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
T-15
引用
收藏
页码：E25 / E25
页数：1
相关论文
共 50 条
  • [31] Guideline Recommendations and Real-World Practice Bridging the Famous Divide
    Wells, Athol U.
    Ravaglia, Claudia
    CHEST, 2024, 165 (02)
  • [32] Clinical features of lenvatinib for unresectable hepatocellular carcinoma in real-world conditions: Multicenter analysis
    Hiraoka, Atsushi
    Kumada, Takashi
    Kariyama, Kazuya
    Takaguchi, Koichi
    Atsukawa, Masanori
    Itobayashi, Ei
    Tsuji, Kunihiko
    Tajiri, Kazuto
    Hirooka, Masashi
    Shimada, Noritomo
    Shibata, Hiroshi
    Ishikawa, Toru
    Ochi, Hironori
    Tada, Toshifumi
    Toyoda, Hidenori
    Nouso, Kazuhiro
    Tsutsui, Akemi
    Itokawa, Norio
    Imai, Michitaka
    Joko, Kouji
    Hiasa, Yoichi
    Michitaka, Kojiro
    CANCER MEDICINE, 2019, 8 (01): : 137 - 146
  • [33] Real-World Vaccine Research and Clinical Practice
    Kumar, Anika
    Acharya, Nisha R.
    JAMA OPHTHALMOLOGY, 2024, 142 (06) : 528 - 529
  • [34] Use of ramucirumab for various treatment lines in real-world practice of patients with advanced hepatocellular carcinoma
    Naoya Kanogawa
    Sadahisa Ogasawara
    Susumu Maruta
    Yotaro Iino
    Masamichi Obu
    Takamasa Ishino
    Keita Ogawa
    Sae Yumita
    Terunao Iwanaga
    Hidemi Unozawa
    Miyuki Nakagawa
    Kisako Fujiwara
    Takafumi Sakuma
    Naoto Fujita
    Ryuta Kojima
    Hiroaki Kanzaki
    Keisuke Koroki
    Kazufumi Kobayashi
    Masanori Inoue
    Soichiro Kiyono
    Masato Nakamura
    Takayuki Kondo
    Tomoko Saito
    Ryo Nakagawa
    Shingo Nakamoto
    Ryosuke Muroyama
    Tetsuhiro Chiba
    Ei Itobayashi
    Yoshihiro Koma
    Ryosaku Azemoto
    Jun Kato
    Naoya Kato
    BMC Gastroenterology, 23
  • [35] Use of ramucirumab for various treatment lines in real-world practice of patients with advanced hepatocellular carcinoma
    Kanogawa, Naoya
    Ogasawara, Sadahisa
    Maruta, Susumu
    Iino, Yotaro
    Obu, Masamichi
    Ishino, Takamasa
    Ogawa, Keita
    Yumita, Sae
    Iwanaga, Terunao
    Unozawa, Hidemi
    Nakagawa, Miyuki
    Fujiwara, Kisako
    Sakuma, Takafumi
    Fujita, Naoto
    Kojima, Ryuta
    Kanzaki, Hiroaki
    Koroki, Keisuke
    Kobayashi, Kazufumi
    Inoue, Masanori
    Kiyono, Soichiro
    Nakamura, Masato
    Kondo, Takayuki
    Saito, Tomoko
    Nakagawa, Ryo
    Nakamoto, Shingo
    Muroyama, Ryosuke
    Chiba, Tetsuhiro
    Itobayashi, Ei
    Koma, Yoshihiro
    Azemoto, Ryosaku
    Kato, Jun
    Kato, Naoya
    BMC GASTROENTEROLOGY, 2023, 23 (01)
  • [36] Safety and efficacy of lenvatinib in patients with unresectable hepatocellular carcinoma (uHCC) in real-world practice in Korea
    Kang, W.
    Kim, J.
    Kim, S. U.
    Seo, Y-S.
    Kim, J.
    Kim, J-H.
    Park, S. Y.
    Baek, Y-H.
    Kim, K.
    Lee, H. L.
    Yoon, K. T.
    Kim, H.
    Cheong, J. Y.
    Hwang, J. S.
    Kim, J. H.
    Kim, K. M.
    Sung, P. S.
    Kim, J. J.
    Kim, D-Y.
    ANNALS OF ONCOLOGY, 2023, 34 : S609 - S609
  • [37] MANAGEMENT OF TUBEROUS SCLEROSIS COMPLEX IN ENGLAND: INSIGHTS INTO REAL-WORLD CLINICAL PRACTICE
    Kingswood, C.
    Dew, R.
    Gray, E.
    VALUE IN HEALTH, 2015, 18 (03) : A249 - A249
  • [38] Clinical effects and emerging issues of atezolizumab plus bevacizumab in patients with advanced hepatocellular carcinoma from Japanese real-world practice
    Nakagawa, Miyuki
    Inoue, Masanori
    Ogasawara, Sadahisa
    Maruta, Susumu
    Okubo, Tomomi
    Itokawa, Norio
    Iino, Yotaro
    Obu, Masamichi
    Haga, Yuki
    Seki, Atsuyoshi
    Kikuchi, Yasuharu
    Kogure, Tadayoshi
    Yumita, Sae
    Ishino, Takamasa
    Ogawa, Keita
    Fujiwara, Kisako
    Iwanaga, Terunao
    Fujita, Naoto
    Sakuma, Takafumi
    Kojima, Ryuta
    Kanzaki, Hiroaki
    Koroki, Keisuke
    Taida, Takashi
    Kobayashi, Kazufumi
    Kiyono, Soichiro
    Nakamura, Masato
    Kanogawa, Naoya
    Kondo, Takayuki
    Nakagawa, Ryo
    Nakamoto, Shingo
    Muroyama, Ryosuke
    Chiba, Tetsuhiro
    Itobayashi, Ei
    Atsukawa, Masanori
    Koma, Yoshihiro
    Azemoto, Ryosaku
    Ito, Kenji
    Mizumoto, Hideaki
    Shinozaki, Masami
    Kato, Jun
    Kato, Naoya
    CANCER, 2023, 129 (04) : 590 - 599
  • [39] Comparative analysis of medical costs after hepatectomy versus radiofrequency ablation in patients with hepatocellular carcinoma in real-world clinical practice
    Terashima, Takeshi
    Higashibeppu, Yoichi
    Yamashita, Tatsuya
    Sakata, Yukinori
    Azuma, Mie
    Munakata, Hiroaki
    Ishii, Mika
    Kaneko, Shuichi
    HEPATOLOGY RESEARCH, 2022, 52 (05) : 471 - 478
  • [40] Multidisciplinary Management of Hepatocellular Carcinoma in Clinical Practice
    Bruera, Gemma
    Cannita, Katia
    Giordano, Aldo Victor
    Manetta, Rosa
    Vicentini, Roberto
    Carducci, Sergio
    Saltarelli, Patrizia
    Iapadre, Nerio
    Coletti, Gino
    Ficorella, Corrado
    Ricevuto, Enrico
    BIOMED RESEARCH INTERNATIONAL, 2014, 2014
12345